ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 173 filers reported holding ZAI LAB LTD in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,581 | -10.2% | 66,648 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,760 | +77.1% | 66,648 | +120.1% | 0.00% | +33.3% |
| Q1 2023 | $994 | -0.8% | 30,282 | -0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,002 | -99.9% | 30,290 | -0.2% | 0.00% | 0.0% |
| Q3 2022 | $1,011,000 | +2.3% | 30,353 | +2.7% | 0.00% | 0.0% |
| Q2 2022 | $988,000 | -87.0% | 29,550 | -1.1% | 0.00% | -84.2% |
| Q1 2022 | $7,585,000 | +195.4% | 29,879 | -28.1% | 0.02% | +216.7% |
| Q4 2021 | $2,568,000 | -2.7% | 41,535 | +66.0% | 0.01% | -14.3% |
| Q3 2021 | $2,638,000 | -35.0% | 25,014 | +7.4% | 0.01% | -41.7% |
| Q2 2021 | $4,061,000 | +43.9% | 23,297 | +5.8% | 0.01% | +33.3% |
| Q1 2021 | $2,822,000 | +6.5% | 22,025 | +7.4% | 0.01% | -10.0% |
| Q4 2020 | $2,649,000 | +86.4% | 20,506 | +17.6% | 0.01% | +66.7% |
| Q3 2020 | $1,421,000 | +378.5% | 17,432 | +381.8% | 0.01% | +200.0% |
| Q2 2020 | $297,000 | +226.4% | 3,618 | +106.3% | 0.00% | +100.0% |
| Q1 2020 | $91,000 | – | 1,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |